English | Español
Caitlin Nordahl | Jan 29, 2016

CBO report showing future increases in Medicare spending spurs health care reform proposals
Caitlin Nordahl | Jan 29, 2016

FDA expands approved use of Bristol-Myers Squibb’s late-stage melanoma treatment
Caitlin Nordahl | Jan 29, 2016

FDA accepts Merck's application for C. difficile infection reoccurrence prevention drug
Caitlin Nordahl | Jan 29, 2016

STRIVE Trial shows increased progression-free survival for men with CRPC
Caitlin Nordahl | Jan 29, 2016

LUX-Lung 7 trial compares two cancer therapies' effectiveness of progression-free survival
Ruth de Jauregui | Jan 28, 2016

European Commission approves continued use of ambroxol, bromhexine products
Amanda Rupp | Jan 28, 2016

AAFP seeks to add preconception care to patient visits
Kasey Schefflin- Emrich | Jan 28, 2016

FDA approves Cosentyx as treatment for two inflammatory conditions

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’